The latest issue of Financial Standard now available as an e-newspaper
|Search Results||Showing 1 - 2 of 2 results for "Ena Respiratory"|
|... forces with CSL, a venture capital fund and universities to fund medical research conducted by Melbourne-based Ena Respiratory. The superannuation funds' investment size was not disclosed by the company. Ena Respiratory has developed INNA-051, a nasal ...|
|... preventative treatment shown to reduce COVID-19 levels by up to 96%. The product, INNA-051, is being developed by Ena Respiratory, and works by stimulating and boosting the innate immune system. The study found that boosting the immune system this way ...|
VanEck has expanded its range of ETFs, announcing two new offerings to join its new Global Clean Energy ETF.
The financial services software company has announced its plans to launch a technological solution to meet the Design and Distribution Obligations (DDO), commencing 5 October 2021.
Capgemini has named a new managing director for Australia and New Zealand, following the recent promotion of Olaf Pietschner.
Victorian-based Ahmed Saad appeared in court after being charged with dishonestly obtaining financial advantage by deception for his role in an illegal retail superannuation scheme.
|Brought to you by|
|Keep up to date, don't be the last to know! Get the Financial Standard Daily Newsletter.|